UBS AM’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Sell |
8,471,619
-7,199,444
| -46% | -$24.7M | 0.01% | 898 |
|
|
2025
Q1 | $34.9M | Buy |
15,671,063
+11,171,063
| +248% | +$24.9M | 0.01% | 764 |
|
|
2024
Q4 | $13.2M | Sell |
4,500,000
-90,103
| -2% | -$264K | ﹤0.01% | 1123 |
|
|
2024
Q3 | $11.9M | Sell |
4,590,103
-8,523
| -0.2% | -$22.2K | ﹤0.01% | 1147 |
|
|
2024
Q2 | $13.6M | Buy |
+4,598,626
| New | +$13.6M | ﹤0.01% | 1010 |
|
|
2022
Q3 | – | Sell |
-31,998
| Closed | -$341K | – | 2738 |
|
|
2022
Q2 | $341K | Buy |
+31,998
| New | +$341K | ﹤0.01% | 2434 |
|